Cardiologia Sperimentale Ferrara

Unità di Ricerca: U.O di Cardiologia

Responsabile/Coordinatore: Prof. Gianluca C. Campo
Sede Universitaria: Azienda Ospedaliero – Universitaria di Ferrara
Dipartimento di Scienze Mediche
Indirizzo: Via Aldo Moro  Nr. 8 – Cap 44124 – Città FERRARA

tel: 0532 237079
e-mail:  cmpglc@unife.it
sito web:

Linee di ricerca:  – infarto miocardico acuto

– terapia antiaggregante

– angioplastica coronarica, stent medicati e impatto delle principali comorbidità nel paziente con cardiopatia ischemica cronica

– polimorfismi genici dei fattori della coagulazione

– danno da riperfusione e funzione mitocondriale

 Laboratori/strumentazione: Paolo Pinton Lab__Signal Transduction, Centro Universitario per le Biotecnologie Ospedaliere, Via Fossato di Mortara 70, Ferrara, Italy.

  Collaborazioni internazionali: 

  1. Aarhus University Hospital, Department of Cardiology, Palle Juul-Jensens Boulevard 99, Skejby, DK-8200 Aarhus N, Denmark
  2. Aarhus University, Institute of Clinical Medicine, Palle Juul-Jensens Boulevard 99, DK-8200 Aarhus N, Denmark
  3. Hospital Clinico San Carlos, Madrid, Spain
  4. Hospital Universitario La Paz, Madrid, Spain
  5. Hospital General Universitario Gregorio Marañón, Madrid, Spain
  6. Hospital Alvaro Conqueiro de Vigo, Vigo, Spain
  7. Hospital de Ciudad Real, Ciudad Real, Spain
  8. Hospital Universitari i Politècnic la Fe, Valencia, Spain
  9. Hospital Universitario Lucus Augusti, Lugo, Spain
  10. Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain
  11. Complejo Hospitalario Universitario de La Coruña, La Coruña, Spain
  12. Hospital de Valladolid, Spain
  13. Centrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii w Nowym Sączu ul. Młyńska 5, 33-300 Nowy Sącz, Poland
  14. Centrum Kardiologii Inwazyjnej Elektroterapii i Angiologii w Ostrowcu Świętokrzyskim ul. Szymanowskiego 13, 27-400 Ostrowiec Świętokrzyski, Poland
  15. Podkarpackie Centrum Interwencji Sercowo-Naczyniowych ul. 800-lecia 26 38-500 Sanok, Poland
  16. Centrum Kardiologii Inwazyjnej Elektroterapii i Angiologii w Oświęcimiu Ul. Wysokie Brzegi 4 32-600 Oświęcim, Poland
  17. Centrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii w Krośnie, ul. Korczyńska 57, 38-400 Krosno, Poland
  18. Centrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii w Pińczowie, ul. Armii Krajowej 22, 28-400 Pińczów, Poland
  19. Szpital Powiatowy im. Tytusa Chałubińskiego w Zakopanem Ul. Kamieniec 10 34-500 Zakopane, Poland

Elenco pubblicazioni del triennio 2017 – 2019: 

  1. Campo G, Di Pasquale G. [The COMPLETE trial and the future of revascularization in patients with ST-elevation myocardial infarction and multivessel disease]. G Ital Cardiol (Rome). 2019Oct;20(10):537-540. doi: 10.1714/3228.32051. Italian. No abstract available.
  2. Biscaglia S, Tebaldi M, Brugaletta S, Cerrato E, Erriquez A, Passarini G, Ielasi A, Spitaleri G, Di Girolamo D, Mezzapelle G, Geraci S, Manfrini M, Pavasini R, Barbato E, Campo G. Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study. JACC Cardiovasc Interv. 2019Sep 21. pii: S1936-8798(19)31302-0. doi: 10.1016/j.jcin.2019.06.003. [Epub ahead of print]
  3. Biscaglia S, Campo G, Sorbets E, Ford I, Fox KM, Greenlaw N, Parkhomenko A, Tardif JC, Tavazzi L, Tendera M, Wetherall K, Ferrari R, Steg PG; CLARIFY investigators. Relationship between physical activity and long-term outcomes in patients with stable coronary artery disease. Eur J Prev Cardiol. 2019Sep 26:2047487319871217. doi: 10.1177/2047487319871217
  4. Pavasini R, Maietti E, Tonet E, Bugani G, Tebaldi M, Biscaglia S, Cimaglia P, Serenelli M, Ruggiero R, Vitali F, Galvani M, Minarelli M, Rubboli A, Bernucci D, Volpato S, Campo G. Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study. Cardiovasc Drugs Ther. 2019Sep 23. doi: 10.1007/s10557-019-06911-y.
  5. Tonet E, Campo G. Reply-Letter to the Editor-Nutritional status and all cause mortality in older adults with acute coronary syndrome. Clin Nutr. 2019Sep 10. pii: S0261-5614(19)33047-X. doi: 10.1016/j.clnu.2019.09.002.
  6. Fogagnolo A, Taccone FS, Campo G, Montanari G, Capatti B, Ferraro G, Erriquez A, Ragazzi R, Creteur J, Volta CA, Spadaro S. Impaired platelet reactivity in patients with septic shock: a proof-of-concept study.2019 Sep 13:1-9. doi: 10.1080/09537104.2019.1663807.
  7. Lewis JP, Backman JD, Reny JL, Bergmeijer TO, Mitchell BD, Ritchie MD, Déry JP, Pakyz RE, Gong L, Ryan K, Kim EY, Aradi D, Fernandez-Cadenas I, Lee MTM, Whaley RM, Montaner J, Gensini GF, Cleator JH, Chang K, Holmvang L, Hochholzer W, Roden DM, Winter S, Altman R, Alexopoulos D, Kim HS, Gawaz M, Bliden K, Valgimigli M, Marcucci R, Campo G, Schaeffeler E, Dridi NP, Wen MS, Shin JG, Fontana P, Giusti B, Geisler T, Kubo M, Trenk D, Siller-Matula JM, Ten Berg JM, Gurbel PA, Schwab M, Klein TE, Shuldiner AR. Pharmacogenomic Polygenic Response Score Predicts Ischemic Events and Cardiovascular Mortality in Clopidogrel-Treated Patients. Eur Heart J Cardiovasc Pharmacother. 2019Sep 3. pii: pvz045. doi: 10.1093/ehjcvp/pvz045.
  8. Vranckx P, Valgimigli M, Eckardt L, Tijssen J, Lewalter T, Gargiulo G, Batushkin V, Campo G, Lysak Z, Vakaliuk I, Milewski K, Laeis P, Reimitz PE, Smolnik R, Zierhut W, Goette A. Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial.2019 Oct 12;394(10206):1335-1343. doi: 10.1016/S0140-6736(19)31872-0. Epub 2019 Sep 3.
  9. Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, Meeks B, Di Pasquale G, López-Sendón J, Faxon DP, Mauri L, Rao SV, Feldman L, Steg PG, Avezum Á, Sheth T, Pinilla-Echeverri N, Moreno R, Campo G, Wrigley B, Kedev S, Sutton A, Oliver R, Rodés-Cabau J, Stanković G, Welsh R, Lavi S, Cantor WJ, Wang J, Nakamya J, Bangdiwala SI, Cairns JA; COMPLETE Trial Steering Committee and Investigators. Complete Revascularization with Multivessel PCI for Myocardial Infarction. N Engl J Med. 2019Oct 10;381(15):1411-1421. doi: 10.1056/NEJMoa1907775. Epub 2019 Sep 1.
  10. Costa F, Brugaletta S, Pernigotti A, Flores-Ulmanzor E, Ortega-Paz L, Cequier A, Iniguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, van Es GA, Backx B, Valgimigli M, Serruys P, Sabaté M. Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention? Circ Cardiovasc Interv. 2019Sep;12(9):e007705. doi: 10.1161/CIRCINTERVENTIONS. 118.007705. Epub 2019 Aug 27.
  11. Leone AM, Campo G, Gallo F, Pavasini R, Basile E, D’Amario D, Tebaldi M, Biscaglia S, Maietti E, Trani C, Crea F. Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis. Int J Cardiol. 2019Jul 10. pii: S0167-5273(19)30395-X. doi: 10.1016/j.ijcard. 2019.07.035.
  12. Pavasini R, Fiorencis A, Tonet E, Gaudenzi E, Balla C, Maietti E, Biscaglia S, Papi A, Ferrari R, Contoli M, Campo G. Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease.2019 Aug;16(3-4):284-291. doi: 10.1080/15412555.2019.1645105. Epub 2019 Jul 29.
  13. Tonet E, Campo G, Maietti E, Formiga F, Martinez-Sellés M, Pavasini R, Biscaglia S, Serenelli M, Sanchis J, Diez-Villanueva P, Bugani G, Vitali F, Ruggiero R, Cimaglia P, Bernucci D, Volpato S, Ferrari R, Ariza-Solé A.
    Nutritional status and all-cause mortality in older adults with acute coronary syndrome. Clin Nutr. 2019Jul 9. pii: S0261-5614(19)30281-X. doi: 10.1016/j.clnu.2019.06.025.
  14. Ferroni L, Gardin C, Dalla Paola L, Campo G, Cimaglia P, Bellin G, Pinton P, Zavan B. Characterization of Dermal Stem Cells of Diabetic Patients.2019 Jul 16;8(7). pii: E729. doi: 10.3390/cells8070729.
  15. Vieceli Dalla Sega F, Fortini F, Aquila G, Campo G, Vaccarezza M, Rizzo P. Notch Signaling Regulates Immune Responses in Atherosclerosis. Front Immunol. 2019May 22;10:1130. doi: 10.3389/fimmu.2019.01130. eCollection 2019.
  16. Gallone G, Armeni P, Verheye S, Agostoni P, Timmers L, Campo G, Ielasi A, Sgura F, Tarantini G, Rosseel L, Zivelonghi C, Leenders G, Stella P, Tebaldi M, Tespili M, D’Amico G, Baldetti L, Ponticelli F, Colombo A, Giannini F. Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients. Eur Heart J Qual Care Clin Outcomes. 2019May 24. pii: qcz027. doi: 10.1093/ehjqcco/qcz027.
  17. Ielasi A, Cerrato E, Geraci S, Campo G, Garro N, Leoncini M, Sganzerla P, Granata F, Ruggiero R, Varbella F, Caramanno G, Grigis G, Tespili M. Sirolimus-Eluting Magnesium Resorbable Scaffold Implantation in Patients with Acute Myocardial Infarction. 2019;142(2):93-96. doi: 10.1159/000499536. Epub 2019 May 10.
  18. Campo G, Maietti E, Tonet E, Biscaglia S, Ariza-Solè A, Pavasini R, Tebaldi M, Cimaglia P, Bugani G, Serenelli M, Ruggiero R, Vitali F, Formiga F, Sanchis J, Galvani M, Minarelli M, Ricci Lucchi G, Ferrari R, Guralnik J, Volpato S. The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome. J Gerontol A Biol Sci Med Sci. 2019May 10. pii: glz123. doi: 10.1093/gerona/glz123.
  19. Westra J, Tu S, Campo G, Qiao S, Matsuo H, Qu X, Koltowski L, Chang Y, Liu T, Yang J, Andersen BK, Eftekhari A, Christiansen EH, Escaned J, Wijns W, Xu B, Holm NR. Diagnostic performance of quantitative flow ratio in prospectively enrolled patients: An individual patient-data meta-analysis. Catheter Cardiovasc Interv. 2019Apr 9. doi: 10.1002/ccd.28283.
  20. Tonet E, Pavasini R, Biscaglia S, Campo G. Frailty in patients admitted to hospital for acute coronary syndrome: when, how and why? J Geriatr Cardiol. 2019Feb;16(2):129-137. doi: 10.11909/j.issn.1671-5411.2019.02.005. Review.
  21. Cimaglia P, Vieceli Dalla Sega F, Vitali F, Lodolini V, Bernucci D, Passarini G, Fortini F, Marracino L, Aquila G, Rizzo P, Ferrari R, Campo G. Effectiveness of a Novel Nutraceutical Compound Containing Red Yeast Rice, Polymethoxyflavones and Antioxidants in the Modulation of Cholesterol Levels in Subjects With Hypercholesterolemia and Low-Moderate Cardiovascular Risk: The NIRVANA Study. Front Physiol. 2019Mar 11;10:217. doi: 10.3389/fphys.2019.00217. eCollection 2019.
  22. Bianco M, Gravinese C, Cerrato E, Nuñez-Gil I, Destefanis P, Luciano A, Biscaglia S, Quadri G, Tizzani E, Corleto A, Giolitto S, Lo Savio L, Campo G, Varbella F, Pozzi R. Management of aspirin intolerance in patients undergoing percutaneous coronary intervention. The role of mono-antiplatelet therapy: a retrospective, multicenter, study. Minerva Cardioangiol. 2019Apr;67(2):94-101. doi: 10.23736/S0026-4725.19.04787-X. Epub 2019 Mar 18.
  23. Jimenez-Quevedo P, Brugaletta S, Cequier A, Iñiguez A, Serra A, Mainar V, Campo G, Tespili M, Nombela-Franco L, Del Trigo M, Gonzalo N, Escaned J, Salinas P, Nuñez-Gil I, Fernandez-Perez C, Fernández-Ortiz A, Macaya C, Serruys PW, Sabate Tenas M. Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial. Catheter Cardiovasc Interv. 2019Mar 20. doi: 10.1002/ccd.28194.
  24. Serenelli M, Pavasini R, Vitali F, Tonet E, Bilotta F, Parodi G, Campo G. Efficacy and safety of alternative oral administrations of P2Y12-receptor inhibitors: Systematic review and meta-analysis. J Thromb Haemost. 2019Jun;17(6):944-950. doi: 10.1111/jth.14434. Epub 2019 Apr 21.
  25. Gargiulo G, Carrara G, Frigoli E, Leonardi S, Vranckx P, Campo G, Varbella F, Calabrò P, Zaro T, Bartolini D, Briguori C, Andò G, Ferrario M, Limbruno U, Colangelo S, Sganzerla P, Russo F, Nazzaro MS, Esposito G, Ferrante G, Santarelli A, Sardella G, Windecker S, Valgimigli M. Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome. J Am Coll Cardiol. 2019Feb 26;73(7):758-774. doi: 10.1016/j.jacc.2018.12.023.
  26. Vitali F, Serenelli M, Airaksinen J, Pavasini R, Tomaszuk-Kazberuk A, Mlodawska E, Jaakkola S, Balla C, Falsetti L, Tarquinio N, Ferrari R, Squeri A, Campo G, Bertini M. CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: Systematic review and individual patient pooled meta-analysis. Clin Cardiol. 2019Mar;42(3):358-364. doi: 10.1002/clc.23147. Epub 2019 Feb 11.
  27. Cerrato E, Bianco M, Bagai A, De Luca L, Biscaglia S, Luciano A, Destefanis P, Quadri G, Meynet I, Gravinese C, Chinaglia A, Goodman SG, Pozzi R, Campo G, Varbella F. Short term outcome following acute phase switch among P2Y12inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies. Int J Cardiol Heart Vasc. 2018 Dec 8;22:39-45. doi: 10.1016/j.ijcha.2018.11.008. eCollection 2019
  28. Pavasini R, Serenelli M, Celis-Morales CA, Gray SR, Izawa KP, Watanabe S, Colin-Ramirez E, Castillo-Martínez L, Izumiya Y, Hanatani S, Onoue Y, Tsujita K, Macdonald PS, Jha SR, Roger VL, Manemann SM, Sanchis J, Ruiz V, Bugani G, Tonet E, Ferrari R, Volpato S, Campo G. Grip strength predicts cardiac adverse events in patients with cardiac disorders: an individual patient pooled meta-analysis.2019 Jun;105(11):834-841. doi: 10.1136/heartjnl-2018-313816. Epub 2018 Nov 19.
  29. Ielasi A, Campo G, Cortese B, Leoncini M, Varricchio A, Brugaletta S, Favaretto E, Fineschi M, Piraino D, Calabria P, Granata F, Pisano F, Mussardo M, Latib A, Tespili M. One-Year Results Following a Pre-Specified ABSORB Implantation Strategy in ST-Elevation Myocardial Infarction (BVS STEMI STRATEGY-IT Study). Cardiovasc Revasc Med. 2019Aug;20(8):700-704. doi: 10.1016/j.carrev.2018.10.003. Epub 2018 Oct 4.
  30. Gargiulo G, Patialiakas A, Piccolo R, Thury A, Colangelo S, Campo G, Tebaldi M, Ungi I, Tondi S, Roffi M, Menozzi A, de Cesare N, Garbo R, Meliga E, Testa L, Gabriel HM, Ferlini M, Liistro F, Dellavalle A, Vranckx P, Briguori C, Windecker  S, Valgimigli M (2019) Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates. Int J Cardiol.
  31. Vitali F, Serenelli M, Airaksinen J, Pavasini R, Tomaszuk-Kazberuk A, Mlodawska E, Jaakkola S, Balla C, Falsetti L, Tarquinio N, Ferrari R, Squeri A, Campo G, Bertini M. (2018) CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis. Clin Cardiol.
  32. Cerrato E, Bianco M, Bagai A, De Luca L, Biscaglia S, Luciano A, Destefanis P, Quadri G, Meynet I, Gravinese C, Chinaglia A, Goodman SG, Pozzi R, Campo G, Varbella F (2018) Short term outcome following acute phase switch among P2Y(12) inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies. Int J Cardiol Heart Vasc.
  33. Stendardo M, Bonci M, Casillo V, Miglio R, Giovannini G, Nardini M, Campo G, Fucili A, Boschetto P (2018) Predicting return to work after acute myocardial infarction: Socio-occupational factors overcome clinical conditions. PLoS One.
  34. Biscaglia S, Tebaldi M, Campo G (2018) Functional Assessment and Acute Coronary Syndrome. JACC Cardiovasc Interv.
  35. Pavasini R, Serenelli M, Celis-Morales CA, Gray SR, Izawa KP, Watanabe S, Colin-Ramirez E, Castillo-Martínez L, Izumiya Y, Hanatani S, Onoue Y, Tsujita K, Macdonald PS, Jha SR, Roger VL, Manemann SM, Sanchis J, Ruiz V, Bugani G, Tonet E, Ferrari R, Volpato S, Campo G (2018) Grip strength predicts cardiac adverse events in patients with cardiac disorders: an individual patient pooled meta-analysis.
  36. Hioki H, Brugaletta S, Ishida K, Campo G, Biscaglia S, Ortega-Paz L, Cortese B, Varricchio A, Latib A, Sabaté M, Tespili M, Ielasi A (2018) Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study. EuroIntervention.
  37. Cesaro A, Gragnano F, Di Girolamo D, Moscarella E, Diana V, Pariggiano I, Alfieri A, Perrotta R, Golino P, Cesaro F, Mercone G, Campo G, Calabrò P (2018) Functional assessment of coronary stenosis: an overview of available techniques. Is quantitative flow ratio a step to the future? Expert Rev Cardiovasc Ther.
  38. Ielasi A, Campo G, Cortese B, Leoncini M, Varricchio A, Brugaletta S, Favaretto E, Fineschi M, Piraino D, Calabria P, Granata F, Pisano F, Mussardo M, Latib A, Tespili M (2018) One-year results following a pre-specified ABSORB implantation strategy in ST-elevation myocardial infarction (BVS STEMI STRATEGY-IT study). Cardiovasc Revasc Med.
  39. Mikus E, Calvi S, Campo G, Pavasini R, Paris M, Raviola E, Panzavolta M, Tripodi A, Ferrari R, Del Giglio M (2018) Full Sternotomy, Hemisternotomy, and Minithoracotomy for Aortic Valve Surgery: Is There a Difference? Ann Thorac Surg.
  40. Schur N, Brugaletta S, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Valgimigli M, Serruys PW, Ademi Z, Schwenkglenks M, Sabaté M.(2018) Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial. PLoS One.
  41. Morciano G, Preti D, Pedriali G, Aquila G, Missiroli S, Fantinati A, Caroccia N, Pacifico S, Bonora M, Talarico A, Morganti C, Rizzo P, Ferrari R, Wieckowski MR, Campo G, Giorgi C, Trapella C, Pinton P (2018) Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F(1)/F(O)-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction. J Med Chem.
  42. Pavasini R, Campo G (2018) The authors reply. Crit Care Med.
  43. Westra J, Andersen BK, Campo G, Matsuo H, Koltowski L, Eftekhari A, Liu T, Di Serafino L, Di Girolamo D, Escaned J, Nef H, Naber C, Barbierato M, Tu S, Neghabat O, Madsen M, Tebaldi M, Tanigaki T, Kochman J, Somi S, Esposito G, Mercone G, Mejia-Renteria H, Ronco F, Bøtker HE, Wijns W, Christiansen EH, Holm NR (2018) Diagnostic Performance of In-Procedure Angiography-Derived Quantitative Flow Reserve Compared to Pressure-Derived Fractional Flow Reserve: The FAVOR II Europe-Japan Study. J Am Heart Assoc.
  44. Barbero U, D’Ascenzo F, Campo G, Kleczyński P, Dziewierz A, Menozzi M, Jiménez Díaz VA, Cerrato E, Raposeiras-Roubín S, Ielasi A, Rognoni A, Fineschi M, Kanji R, Jaguszewski MJ, Picchi A, Andò G, Soraci E, Mancone M, Sardella G, Calcagno S, Gallo F, Huczek Z, Krakowian M, Verardi R, Montefusco A, Omedè P, Lococo M, Moretti C, D’Amico M, Rigattieri S, Gaita F, Rinaldi M, Escaned J (2018) Safety of FFR-guided revascularisation deferral in Anatomically prognostiC diseasE (FACE: CARDIOGROUP V STUDY): A prospective multicentre study. Int J Cardiol.
  45. Tebaldi M, Biscaglia S, Tumscitz C, Del Franco A, Gallo F, Spitaleri G, Fileti L, Serenelli M, Tonet E, Erriquez A, Campo G, Ferrari R (2018) Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study. Cardiology.
  46. Tebaldi M, Biscaglia S, Fineschi M, Musumeci G, Marchese A, Leone AM, Rossi, ML, Stefanini G, Maione A, Menozzi A, Tarantino F, Lodolini V, Gallo F, Barbato E, Tarantini G, Campo G (2018) Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study. JACC Cardiovasc Interv.
  47. Xaplanteris P, Fournier S, Pijls NHJ, Fearon WF, Barbato E, Tonino PAL, Engstrøm T, Kääb S, Dambrink JH, Rioufol G, Toth GG, Piroth Z, Witt N, Fröbert O, Kala P, Linke A, Jagic N, Mates M, Mavromatis K, Samady H, Irimpen A, Oldroyd K, Campo G, Rothenbühler M, Jüni P, De Bruyne B (2018) FAME 2 Investigators. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. N Engl J Med.
  48. Tonet E, Maietti E, Chiaranda G, Vitali F, Serenelli M, Bugani G, Mazzoni G, Ruggiero R, Myers J, Villani GQ, Corvi U, Pasanisi G, Biscaglia S, Pavasini R, Lucchi GR, Sella G, Ferrari R, Volpato S, Campo G, Grazzi G (2018) Physical activity intervention for elderly patients with reduced physical performance after acutecoronary syndrome (HULK study): rationale and design of a randomized clinical trial. BMC Cardiovasc Disord.
  49. Tonet E, Bernucci D, Morciano G, Campo G (2018) Pharmacological protection of reperfusion injury in ST segment elevation myocardial infarction. Gone with the wind? Postepy Kardiol Interwencyjnej.
  50. Del Giglio M, Mikus E, Nerla R, Micari A, Calvi S, Tripodi A, Campo G, Maietti E, Castriota F, Cremonesi A (2018) Right anterior mini-thoracotomy vs. conventional sternotomy for aortic valve replacement: a propensity-matched comparison. J Thorac Dis.
  51. Vieceli Dalla Sega F, Fortini F, Aquila G, Pavasini R, Biscaglia S, Bernucci D, Del Franco A, Tonet E, Rizzo P, Ferrari R, Campo G (2018) Ticagrelor Improves Endothelial Function by Decreasing Circulating Epidermal Growth Factor (EGF). Front Physiol.
  52. Bergmeijer TO, Reny JL, Pakyz RE, Gong L, Lewis JP, Kim EY, Aradi D, Fernandez-Cadenas I, Horenstein RB, Lee MTM, Whaley RM, Montaner J, Gensini GF, Cleator JH, Chang K, Holmvang L, Hochholzer W, Roden DM, Winter S, Altman RB, Alexopoulos D, Kim HS, Déry JP, Gawaz M, Bliden K, Valgimigli M, Marcucci R, Campo G, Schaeffeler E, Dridi NP, Wen MS, Shin JG, Simon T, Fontana P, Giusti B, Geisler T, Kubo M, Trenk D, Siller-Matula JM, Ten Berg JM, Gurbel PA, Hulot JS, Mitchell BD, Schwab M, Ritchie MD, Klein TE, Shuldiner AR (2018) ICPC Investigators. Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC). Am Heart J.
  53. Secco GG, Tebaldi M, Parisi R, Cuculo A, Di Mario C, Sangiorgio P, Ielasi A, Centola A, Fattori R, Vercellino M, Longo G, Pistis G, Biscaglia S, Ruggiero A,Marino PN, Campo G (2018) One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study). J Invasive Cardiol.
  54. Spitaleri G, Brugaletta S, Scalone G, Moscarella E, Ortega-Paz L, Pernigotti A, Gomez-Lara J, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Valgimigli M, Serruys PW, Sabaté M (2018) Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial). Am J Cardiol.
  55. Gargiulo G, Carrara G, Frigoli E, Vranckx P, Leonardi S, Ciociano N, Campo G,Varbella F, Calabrò P, Garducci S, Iannone A, Briguori C, Andò G, Crimi G, Limbruno U, Garbo R, Sganzerla P, Russo F, Lupi A, Cortese B, Ausiello A, Ierna S, Esposito G, Zavalloni D, Santarelli A, Sardella G, Tresoldi S, de Cesare N, Sciahbasi A, Zingarelli A, Tosi P, van ‘t Hof A, Omerovic E, Brugaletta S, Windecker S, Valgimigli M (2018) Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes. J Am Coll Cardiol.
  56. Spitaleri G, Tebaldi M, Biscaglia S, Westra J, Brugaletta S, Erriquez A,Passarini G, Brieda A, Leone AM, Picchi A, Ielasi A, Girolamo DD, Trani C,Ferrari R, Reiber JHC, Valgimigli M, Sabatè M, Campo G (2018) Quantitative Flow RatioIdentifies Nonculprit Coronary Lesions Requiring Revascularization in PatientsWith ST-Segment-Elevation Myocardial Infarction and Multivessel Disease. Circ Cardiovasc Interv.
  57. Campo G, Gallo F, Bugani G, Pavasini R, Fineschi M (2018) How the functional assessment of culprit and non-culprit lesions may improve stratification and treatment of STEMI patients. Minerva Cardioangiol.
  58. Gargiulo G, Heg D, Ferrari F, Percoco G, Campo G, Tumscitz C, Colombo F,Zuffi A, Castriota F, Cremonesi A, Windecker S, Valgimigli M (2017) Stent and Dual Antiplatelet Therapy Duration Comparisons in the Setting of a Multicenter Randomized Controlled Trial: Can the Operator Experience Affect the Study Results? J Am Heart Assoc.
  59. Spitaleri G, Moscarella E, Brugaletta S, Pernigotti A, Ortega-Paz L, Gomez-Lara J, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Valgimigli M, Serruys PW, Sabaté M (2018) Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of  the EXAMINATION trial. EuroIntervention.
  60. Bugani G, Lanzillotti V, Filippini E, Di Pasquale G, Campo G (2018) Coronary revascularization in patients with ST-elevation myocardial infarction and multivessel disease. G Ital Cardiol (Rome).
  61. Chevalier B, Cequier A, Dudek D, Haude M, Carrie D, Sabaté M, Windecker S, Reith S, de Sousa Almeida M, Campo G, Iñiguez A, Onuma Y, Serruys PW (2018) Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial). EuroIntervention.
  62. Contoli M, Campo G, Pavasini R, Marchi I, Pauletti A, Balla C, Spanevello A, Ferrari R, Papi A (2018) Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients. Eur J Intern Med.
  63. Gargiulo G, Heg D, Ferrari F, Percoco G, Campo G, Tumscitz C, Colombo F,Zuffi A, Castriota F, Cremonesi A, Windecker S, Valgimigli M (2017) Stent and Dual Antiplatelet Therapy Duration Comparisons in the Setting of a Multicenter Randomized Controlled Trial: Can the Operator Experience Affect the Study Results? J Am Heart Assoc.
  64. Pavasini R, Vieceli Dalla Sega F, Gallo F, Passarini G, Papi A, Contoli M, Campo G (2017) Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial. Eur Respir J.
  65. Ielasi A, Campo G, Rapetto C, Varricchio A, Cortese B, Brugaletta S, Geraci S, Vicinelli P, Scotto di Uccio F, Secco GG, Poli A, Nicolini E, Ishida K, Latib A, Tespili M (2017) A Prospective Evaluation of a Pre-Specified Absorb BVS Implantation Strategy in ST-Segment Elevation Myocardial Infarction: The BVS STEMI STRATEGY-IT Study. JACC Cardiovasc Interv.
  66. Moscarella E, Ielasi A, De Angelis MC, di Uccio FS, Cerrato E, De Rosa R, Campo G, Varricchio A (2017) Are acute coronary syndromes an ideal scenario for bioresorbable vascular scaffold implantation? J Thorac Dis.
  67. Biscaglia S, Erriquez A, Bernucci D, Bugani G, Favaretto E, Campo G (2017) BRSimplantation in long lesions requiring device overlapping: myth or reality? J Thorac Dis.
  68. Serenelli M, Biscaglia S, Tonet E, Poli A, Nicolini E, Ielasi A, Erriquez A, Campo G (2017) The impact of the 3-year ABSORB II trial results on my clinical practice: an Italian survey. J Thorac Dis.
  69. Pavasini R, Serenelli M, Gallo F, Bugani G, Geraci S, Vicinelli P, Campo G (2017) Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: systematic review and meta-analysis of randomized clinical trials. J Thorac Dis.
  70. Ielasi A, Campo G (2017) Bioresorbable coronary scaffolds in 2017. J Thorac Dis.
  71. Moscarella E, Spitaleri G, Brugaletta S, Sentí Farrarons S, Pernigotti A, Ortega-Paz L, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Valgimigli M, Serruys PW, Sabaté M (2017) Impact of Body Mass Index on 5-Year Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction After Everolimus-Eluting or Bare-Metal Stent Implantation. Am J Cardiol.
  72. Biscaglia S, Campo G (2017) Meta-Analyses on DAPT Length: Chasing the Calm After the (Perfect) Storm. J Am Coll Cardiol.
  73. Pavasini R, Cirillo C, Campo G, Nobre Menezes M, Biscaglia S, Tonet E, Ferrari R, Patel BV, Price S (2017) Extracorporeal Circulatory Support in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis. Crit Care Med.
  74. Biscaglia S, Tonet E, Pavasini R, Serenelli M, Bugani G, Cimaglia P, Gallo F,Spitaleri G, Del Franco A, Aquila G, Vieceli Dalla Sega F, Tebaldi M, Tumscitz C,Ferrari R, Campo G (2017) A counseling program on nuisance bleeding improves quality oflife in patients on dual antiplatelet therapy: A randomized controlled trial. PLoS One.
  75. Campo G, Pavasini R, Morciano G, Lincoff MA, C Gibson M, Kitakaze M, Lonborg J, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, Biscaglia S, Neil BJ, Asakura M, Engstrom T, Jones DA, Dawson D, Ferrari R, Pinton P, Ottani F (2017) Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention. Data Brief.
  76. Tumscitz C, Campo G, Tebaldi M, Gallo F, Pirani L, Biscaglia S (2017) Safety and Feasibility of Transradial Mini-Invasive Balloon Aortic Valvuloplasty: A Pilot Study. JACC Cardiovasc Interv.
  77. Biscaglia S, Campo G (2017) Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU (Gauging coronary Healing with bioresorbable Scaffolding plaTforms in EUrope) Registry. JACC Cardiovasc Interv.
  78. Campo G, Pavasini R, Morciano G, Lincoff AM, Gibson CM, Kitakaze M, LonborgJ, Ahluwalia A, Ishii H, Frenneaux M, Ovize M, Galvani M, Atar D, Ibanez B, Cerisano G, Biscaglia S, Neil BJ, Asakura M, Engstrom T, Jones DA, Dawson D, Ferrari R, Pinton P, Ottani F (2017) Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials. Int J Cardiol.
  79. Pavasini R, Ruggerini S, Grapsa J, Biscaglia S, Tumscitz C, Serenelli M, Boriani G, Squeri A, Campo G (2017) Role of the tricuspid regurgitation after mitraclip and transcatheter aortic valve implantation: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging.
  80. Bonora M, Morganti C, Morciano G, Pedriali G, Lebiedzinska-Arciszewska M, Aquila G, Giorgi C, Rizzo P, Campo G, Ferrari R, Kroemer G, Wieckowski MR, Galluzzi L, Pinton P (2017) Mitochondrial permeability transition involves dissociation of F(1)F(O) ATP synthase dimers and C-ring conformation. EMBO Rep.
  81. Morciano G, Bonora M, Campo G, Aquila G, Rizzo P, Giorgi C, Wieckowski MR, Pinton P (2017) Mechanistic Role of mPTP in Ischemia-Reperfusion Injury. Adv Exp Med Biol.
  82. Ferrari R, Campo G (2017) Operator, Drug or Device: Who Will Break Down Acute Stent Thrombosis? Cardiology.
  83. Vieceli Dalla Sega F, Aquila G, Fortini F, Vaccarezza M, Secchiero P, Rizzo P, Campo G (2017) Context-dependent function of ROS in the vascular endothelium: The role of the Notch pathway and shear stress. Biofactors.
  84. Menozzi A, Campo GC, Guiducci V, Dall’Ara G, Santarelli A, Sbarzaglia P, Balducelli M, Magnavacchi P, Sgura F, Losi L, Vignali L, Casella G, Steffanon L, Tarantino F, Saia F (2017) Bioresorbable vascular scaffolds: clinical experience of the Emilia-Romagna Region, Italy. G Ital Cardiol (Rome).
  85. Campo G, Vieceli Dalla Sega F, Pavasini R, Aquila G, Gallo F, Fortini F, Tonet E, Cimaglia P, Del Franco A, Pestelli G, Pecoraro A, Contoli M, Balla C, Biscaglia S, Rizzo P, Ferrari R (2017) Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease. Thromb Haemost.
  86. Vranckx P, Frigoli E, Rothenbühler M, Tomassini F, Garducci S, Andò G, Picchi A, Sganzerla P, Paggi A, Ugo F, Ausiello A, Sardella G, Franco N, Nazzaro M, de Cesare N, Tosi P, Falcone C, Vigna C, Mazzarotto P, Di Lorenzo E, Moretti C, Campo G, Penzo C, Pasquetto G, Heg D, Jüni P, Windecker S, Valgimigli M; MATRIX Investigators (2017) Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation. Eur Heart J.
  87. Ortega-Paz L, Brugaletta S, Giacchi G, Ishida K, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Valgimigli M, Serruys PW, Sabaté M (2017) Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial. EuroIntervention.
  88. Pavasini R, Tavazzi G, Biscaglia S, Guerra F, Pecoraro A, Zaraket F, Gallo F, Spitaleri G, Contoli M, Ferrari R, Campo G (2017) Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis. Chron Respir Dis.
  89. Ferrari R, Balla C, Malagù M, Guardigli G, Morciano G, Bertini M, Biscaglia S, Campo G (2017) Reperfusion Damage – A Story of Success, Failure, and Hope. Circ J.
  90. Campo G, Pavasini R, Maietti E, Tonet E, Cimaglia P, Scillitani G, Bugani G, Serenelli M, Zaraket F, Balla C, Trevisan F, Biscaglia S, Sassone B, Galvani M, Ferrari R, Volpato S (2017) The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study. Aging Clin Exp Res.
  91. Ielasi A, Varricchio A, Campo G, Leoncini M, Cortese B, Vicinelli P, Brugaletta S, di Uccio FS, Latib A, Tespili M (2017) A prospective evaluation of a standardized strategy for the use of a polymeric everolimus-eluting bioresorbable scaffold in ST-segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY-IT study. Catheter Cardiovasc Interv.